Skip to content
naulon
Not checkedNot checked for notices yet.

Rat Model of Cockayne Syndrome Neurological Disease

Yingying Xu, Zhenzhen Wu, Lingyun Liu and 2 more

Cell Reports · 2019

doi:10.1016/j.celrep.2019.09.028 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Summary: Cockayne syndrome (CS) is a rare genetic neurodevelopmental disorder, characterized by a deficiency in transcription-coupled subpathway of nucleotide excision DNA repair (TC-NER). Mutation of the Cockayne syndrome B (CSB) gene affects basal transcription, which is considered a major cause of CS neurologic dysfunction. Here, we generate a rat model by mimicking a nonsense mutation in the CSB gene. In contrast to that of the Csb−/− mouse models, the brains of the CSB-deficient rats are more profoundly affected. The cerebellar cortex shows significant atrophy and dysmyelination. Aberrant foliation of the cerebellum and deformed hippocampus are visible. The white matter displays high glial fibrillary acidic protein (GFAP) staining indicative of reactive astrogliosis. RNA sequencing (RNA-seq) analysis reveals that CSB deficiency affects the expression of hundreds of genes, many of which are neuronal genes, suggesting that transcription dysregulation could contribute to the neurologic disease seen in the CSB rat models.: Xu et al. report a CRISPR/Cas9-edited rat displaying a nonsense mutation in the CSB gene, which can be used as an appropriate animal model for the DNA repair and neurodevelopment characteristics of Cockayne syndrome disease. Keywords: Cockayne syndrome rat model, neurodevelopmental disorder, CRISPR/Cas9, transcription dysregulation, CSB

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.